Literature DB >> 22077552

Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms.

Federica Sotgia1, Ubaldo E Martinez-Outschoorn, Anthony Howell, Richard G Pestell, Stephanos Pavlides, Michael P Lisanti.   

Abstract

Caveolins are a family of membrane-bound scaffolding proteins that compartmentalize and negatively regulate signal transduction. Recent studies have implicated a loss of caveolin-1 (Cav-1) expression in the pathogenesis of human cancers. Loss of Cav-1 expression in cancer-associated fibroblasts results in an activated tumor microenvironment, thereby driving early tumor recurrence, metastasis, and poor clinical outcome in breast and prostate cancers. We describe various paracrine signaling mechanism(s) by which the loss of stromal Cav-1 promotes tumor progression, including fibrosis, extracellular matrix remodeling, and the metabolic/catabolic reprogramming of cancer-associated fibroblast, to fuel the growth of adjacent tumor cells. It appears that oxidative stress is the root cause of initiation of the loss of stromal Cav-1 via autophagy, which provides further impetus for the use of antioxidants in anticancer therapy. Finally, we discuss the functional role of Cav-1 in epithelial cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22077552     DOI: 10.1146/annurev-pathol-011811-120856

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  140 in total

Review 1.  STRIPAK complexes in cell signaling and cancer.

Authors:  Z Shi; S Jiao; Z Zhou
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

2.  Exploiting tumor metabolism: challenges for clinical translation.

Authors:  Matthew G Vander Heiden
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

4.  Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.

Authors:  Agnieszka K Witkiewicz; Diana Whitaker-Menezes; Abhijit Dasgupta; Nancy J Philp; Zhao Lin; Ricardo Gandara; Sharon Sneddon; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

Review 5.  Metabolic Interactions in the Tumor Microenvironment.

Authors:  Costas A Lyssiotis; Alec C Kimmelman
Journal:  Trends Cell Biol       Date:  2017-07-19       Impact factor: 20.808

6.  Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome.

Authors:  Meijing Ren; Fangfang Liu; Yufen Zhu; Yaqing Li; Ronggang Lang; Yu Fan; Feng Gu; Xinmin Zhang; Li Fu
Journal:  Virchows Arch       Date:  2014-07-01       Impact factor: 4.064

7.  Rapid Isolation of the Mitoribosome from HEK Cells.

Authors:  Shintaro Aibara; Juni Andréll; Vivek Singh; Alexey Amunts
Journal:  J Vis Exp       Date:  2018-10-04       Impact factor: 1.355

8.  Transcription factor networks in invasion-promoting breast carcinoma-associated fibroblasts.

Authors:  A Siletz; E Kniazeva; J S Jeruss; L D Shea
Journal:  Cancer Microenviron       Date:  2012-10-23

9.  JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.

Authors:  Michael P Lisanti; Aristotelis Tsirigos; Stephanos Pavlides; Kimberley Jayne Reeves; Maria Peiris-Pagès; Amy L Chadwick; Rosa Sanchez-Alvarez; Rebecca Lamb; Anthony Howell; Ubaldo E Martinez-Outschoorn; Federica Sotgia
Journal:  Cell Cycle       Date:  2013-12-05       Impact factor: 4.534

10.  Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin.

Authors:  Rosa Sanchez-Alvarez; Ubaldo E Martinez-Outschoorn; Rebecca Lamb; James Hulit; Anthony Howell; Ricardo Gandara; Marina Sartini; Emanuel Rubin; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2012-12-20       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.